PharmaEngine, Inc. Statistics
PharmaEngine, Inc. (4162) Stock Statistics & Valuation Metrics
Total Valuation
PharmaEngine, Inc. has a market cap or net worth of TWD 7.44B. The enterprise value is TWD 3.73B.
- Market Cap
- TWD 7.44B
- Enterprise Value
- TWD 3.73B
Share Statistics
PharmaEngine, Inc. has 143,677,640 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 143,677,640
- Owned by Insiders
- ―
- Owned by Institutions
- 2.46%
Financial Efficiency
PharmaEngine, Inc.’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 6.52%.
- Return on Equity (ROE)
- 0.08
- Return on Assets (ROA)
- 0.08
- Return on Invested Capital (ROIC)
- 6.52%
- Return on Capital Employed (ROCE)
- 0.09
- Revenue Per Employee
- 20.25M
- Profits Per Employee
- 8.61M
- Employee Count
- 45
- Asset Turnover
- 0.18
- Inventory Turnover
- 1.55
Valuation Ratios
The current PE Ratio of PharmaEngine, Inc. is 14.03. PharmaEngine, Inc.’s PEG ratio is -0.21.
- PE Ratio
- 14.03
- PS Ratio
- 7.37
- PB Ratio
- 1.54
- Price to FCF
- 13.99
- Price to Operating Cash Flow
- 14.02
- PEG Ratio
- -0.21
Income Statement
In the last 12 months, PharmaEngine, Inc. had revenue of 911.42M and earned 387.64M in profits. Earnings per share was 2.70.
- Revenue
- 911.42M
- Gross Profit
- 849.51M
- Operating Income
- 425.46M
- Pretax Income
- 509.29M
- Net Income
- 387.64M
- EBITDA
- 519.48M
- Earnings Per Share (EPS)
- 2.70
Cash Flow
In the last 12 months, operating cash flow was 540.65M and capital expenditures -339,000, giving a free cash flow of 540.31M billion.
- Operating Cash Flow
- 540.65M
- Free Cash Flow
- 540.31M
- Free Cash Flow per Share
- 3.75
Dividends & Yields
PharmaEngine, Inc. pays an annual dividend of ―, resulting in a dividend yield of 3.78%
- Dividend Per Share
- ―
- Dividend Yield
- 3.78%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 7.20%
- Earnings Yield
- 7.16%
Stock Price Statistics
- Beta
- 0.42
- 52-Week Price Change
- -24.21%
- 50-Day Moving Average
- 56.13
- 200-Day Moving Average
- 57.64
- Relative Strength Index (RSI)
- 31.81
- Average Volume (3m)
- 274.88K
Important Dates
PharmaEngine, Inc. upcoming earnings date is Nov 11, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Jul 30, 2026
- Next Earnings Date
- Nov 11, 2026
- Ex-Dividend Date
- ―
Financial Position
PharmaEngine, Inc. as a current ratio of 27.17, with Debt / Equity ratio of 0.86%
- Current Ratio
- 27.17
- Quick Ratio
- 26.96
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -2.97
- Interest Coverage Ratio
- 3060.87
Taxes
In the past 12 months, PharmaEngine, Inc. has paid 121.65M in taxes.
- Income Tax
- 121.65M
- Effective Tax Rate
- 0.24
Enterprise Valuation
PharmaEngine, Inc. EV to EBITDA ratio is 10.00, with an EV/FCF ratio of 11.77.
- EV to Sales
- 6.21
- EV to EBITDA
- 10.00
- EV to Free Cash Flow
- 11.77
- EV to Operating Cash Flow
- 11.77
Balance Sheet
PharmaEngine, Inc. has TWD 5.07B in cash and marketable securities with TWD 37.78M in debt, giving a net cash position of TWD 5.03B billion.
- Cash & Marketable Securities
- TWD 5.07B
- Total Debt
- TWD 37.78M
- Net Cash
- TWD 5.03B
- Net Cash Per Share
- TWD 35.04
- Tangible Book Value Per Share
- TWD 34.06
Margins
Gross margin is 93.62%, with operating margin of 47.32%, and net profit margin of 52.56%.
- Gross Margin
- 93.62%
- Operating Margin
- 47.32%
- Pretax Margin
- 63.07%
- Net Profit Margin
- 52.56%
- EBITDA Margin
- 62.04%
- EBIT Margin
- 61.00%
Analyst Forecast
The average price target for PharmaEngine, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -58.69%
- EPS Growth Forecast
- -66.96%
